BNBX
Applied DNA Sciences, Inc.
NASDAQ: BNBX · FINANCIAL SERVICES · ASSET MANAGEMENT
$0.53
+3.91% today
Updated 2026-04-30
Market cap
$2.93M
P/E ratio
0.00
P/S ratio
1.60x
EPS (TTM)
$282.39
Dividend yield
—
52W range
$0 – $14
Volume
1.0M
Applied DNA Sciences, Inc. (BNBX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$0.53
12-Month target
$1,920.25
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.